Clinical Trial Update: Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating hyperpolarized carbon-13 pyruvate imaging to aid the diagnosis of glioma in patients with brain tumors; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasm
• Glioma

Drugs mentioned

• Hyperpolarized Carbon-13 Pyruvate (Hyperpolarized carbon-13 pyruvate)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Primary Brain Neoplasm | Phase 1 | Status: RECRUITING